CoChat

Elevated circulating follistatin associates with an increased risk of type 2 diabetes

Open access
Wu, Chuanyan, Borné, Yan, Gao, Rui, López Rodriguez, Maykel, Roell, William C., Wilson, Jonathan M., Regmi, Ajit, Luan, Cheng, Aly, Dina Mansour, Peter, Andreas, Machann, Jürgen, Staiger, Harald, Fritsche, Andreas, Birkenfeld, Andreas L., Tao, Rongya, Wagner, Robert, Canouil, Mickaël, Hong, Mun-Gwan, Schwenk, Jochen M., Ahlqvist, Emma, Kaikkonen, Minna U., Nilsson, Peter, Shore, Angela C., Khan, Faisel, Natali, Andrea, Melander, Olle, Orho-Melander, Marju, Nilsson, Jan, Häring, Hans-Ulrich, Renström, Erik, Wollheim, Claes B., Engström, Gunnar, Weng, Jianping, Pearson, Ewan R., Franks, Paul W., White, Morris F., Duffin, Kevin L., Vaag, Allan Arthur, Laakso, Markku, Stefan, Norbert, Groop, Leif, De Marinis, Yang · 2021 · Nature Communications
Cited by 67

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

The hepatokine follistatin is elevated in patients with type 2 diabetes (T2D) and promotes hyperglycemia in mice. Here we explore the relationship of plasma follistatin levels with incident T2D and mechanisms involved. Adjusted hazard ratio (HR) per standard deviation (SD) increase in follistatin levels for T2D is 1.24 (CI: 1.04–1.47, p < 0.05) during 19-year follow-up (n = 4060, Sweden); and 1.31 (CI: 1.09–1.58, p < 0.01) during 4-year follow-up (n = 883, Finland). High circulating follistatin associates with adipose tissue insulin resistance and non-alcoholic fatty liver disease (n = 210, Germany). In human adipocytes, follistatin dose-dependently increases free fatty acid release. In genome-wide association study (GWAS), variation in the glucokinase regulatory protein gene (GCKR) associates with plasma follistatin levels (n = 4239, Sweden; n = 885, UK, Italy and Sweden) and GCKR regulates follistatin secretion in hepatocytes in vitro. Our findings suggest that GCKR regulates follistatin secretion and that elevated circulating follistatin associates with an increased risk of T2D by inducing adipose tissue insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-26536-w

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 19

  1. Jones, K. L. et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc. Natl Acad. Sci. USA 104, 16239–16244 (2007). · DOI · Paper page
  2. Medeiros, E. F., Phelps, M. P., Fuentes, F. D. & Bradley, T. M. Overexpression of follistatin in trout stimulates increased muscling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R235–R242 (2009). · DOI · Paper page
  3. Nakamura, T. et al. Activin-binding protein from rat ovary is follistatin. Science 247, 836–838 (1990). · DOI · Paper page
  4. Zimmers, T. A. et al. Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486–1488 (2002). · DOI · Paper page
  5. Zhao, C. et al. Overcoming Insulin Insufficiency by Forced Follistatin Expression in beta-cells of db/db Mice. Mol. Ther. 23, 866–874 (2015). · DOI · Paper page
  6. Orho-Melander, M. et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57, 3112–3121 (2008). · DOI · Paper page
  7. Borne, Y. et al. Complement C3 Associates With Incidence of Diabetes, but No Evidence of a Causal Relationship. J. Clin. Endocrinol. Metab. 102, 4477–4485 (2017). · DOI
  8. Rees, M. G. et al. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia 55, 114–122 (2012). · DOI · Paper page
  9. Lopez, M. Rodriguez et al., Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells. Genome Med 9, 63 (2017). · DOI
  10. Lloyd, D. J. et al. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.Nature 504, 437–440 (2013). · DOI
  11. Staehr, P. et al. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes. 52, 260–267 (2003). · DOI · Paper page
  12. Sakamoto, Y. et al. Determination of free follistatin levels in sera of normal subjects and patients with various diseases. Eur J Endocrinol. 135, 345–351 (1996). · DOI
  13. Vamvini, M. T., Aronis, K. N., Chamberland, J. P. & Mantzoros, C. S. Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males. J Clin Endocrinol Metab. 96, 3416–3426 (2011). · DOI · Paper page
  14. Grimsby, J. et al. Characterization of glucokinase regulatory protein-deficient mice. J Biol Chem. 275, 7826–7831 (2000). · DOI · Paper page
  15. Jin, L. et al. Role of glucokinase in the subcellular localization of glucokinase regulatory protein. Int J Mol Sci. 16, 7377–7393 (2015). · DOI
  16. Farrelly, D. et al. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc Natl Acad Sci USA. 96, 14511–14516 (1999). · DOI · Paper page
  17. Brouwers, M., Jacobs, C., Bast, A., Stehouwer, C. D. A. & Schaper, N. C. Modulation of glucokinase regulatory protein: A double-edged sword? Trends Mol Med. 21, 583–594 (2015). · DOI
  18. Mattisson, I. Y. et al. Elevated markers of death receptor-activated apoptosis are associated with increased risk for development of diabetes and cardiovascular disease. EBioMedicine. 26, 187–197 (2017). · DOI
  19. Bao, X. et al. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort. Diabetologia. 62, 78–86 (2019). · DOI · Paper page

Cited by

See all 67

Metadata

Authors
Wu, C., Borné, Y., Gao, R., López Rodriguez, M., Roell, W. C., Wilson, J. M., Regmi, A., Luan, C., Aly, D. M., Peter, A., Machann, J., Staiger, H., Fritsche, A., Birkenfeld, A. L., Tao, R., Wagner, R., Canouil, M., Hong, M.-G., Schwenk, J. M., Ahlqvist, E., Kaikkonen, M. U., Nilsson, P., Shore, A. C., Khan, F., Natali, A., Melander, O., Orho-Melander, M., Nilsson, J., Häring, H.-U., Renström, E., Wollheim, C. B., Engström, G., Weng, J., Pearson, E. R., Franks, P. W., White, M. F., Duffin, K. L., Vaag, A. A., Laakso, M., Stefan, N., Groop, L., & De Marinis, Y.
Venue
Nature Communications
Published
2021-11-10
Volume
12
Issue
1
Pages
6486-6486
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3213389536
Cited by
67
References
17
FWCI
7.05
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Vetenskapsrådet (2009-1039)
  • Stiftelsen för Strategisk Forskning (IRC15-0067)
  • European Foundation for the Study of Diabetes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated circulating follistatin associates with an increased risk of type 2 diabetes. https://app.cochat.ai/papers/10.1038/s41467-021-26536-w
The paper
Wu, C., Borné, Y., Gao, R., López Rodriguez, M., Roell, W. C., Wilson, J. M., Regmi, A., Luan, C., Aly, D. M., Peter, A., Machann, J., Staiger, H., Fritsche, A., Birkenfeld, A. L., Tao, R., Wagner, R., Canouil, M., Hong, M.-G., Schwenk, J. M., . . . De Marinis, Y. (2021). Elevated circulating follistatin associates with an increased risk of type 2 diabetes. Nature Communications. https://doi.org/10.1038/s41467-021-26536-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.